GeneFirst
Company

Last deal

$3.4M
Local Amount - EUR 2.9M

Amount

Grant

Stage

01.11.2017

Date

1

all rounds

$3.4M

Total amount

General

About Company
GeneFirst is a molecular diagnostics company that offers affordable and easy-to-use technologies for accurate disease diagnosis.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2011

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

The company specializes in infectious disease, cancer diagnostics, and personalized medicine, and provides molecular diagnostics kits and devices that allow for the simultaneous detection of multiple targets in one reaction. GeneFirst's products are used by researchers, clinicians, and drug companies to deliver safe and effective medicines. They also offer collaboration opportunities for those in need of detecting multiple targets in their work with bacteria, viruses, or fungus.
Contacts

location

Phone number

Social url